Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AXSM vs $BLTE | Chartloom

Compare

$AXSM vs $BLTE

Axsome Therapeutics Inc · Belite Bio Inc

AXSM

Axsome Therapeutics Inc

BLTE

Belite Bio Inc

Compare $AXSM vs $BLTE

Comparing Axsome Therapeutics Inc and Belite Bio Inc

AXSMAxsome Therapeutics Inc

BLTEBelite Bio Inc

AXSMAxsome Therapeutics Inc

Market cap

$8.04B

P/E (TTM)

—

Forward P/E (NTM)

211.90x

Forward P/S (NTM)

6.58x

Rev growth (TTM)

56.9%

YTD performance

-12.5%

52W performance

28.4%

FCF yield

-0.9%

BLTEBelite Bio Inc

Market cap

$5.70B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.92x

Rev growth (TTM)

—

YTD performance

-4.6%

52W performance

91.6%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AXSM

BLTE

Detailed metrics comparison

AXSM

Axsome Therapeutics Inc

BLTE

Belite Bio Inc

Market Cap

AXSM$8.04B

BLTE$5.70B

Enterprise Value

AXSM$7.93B

BLTE$5.70B

Price

AXSM$156.32

BLTE$151.87

P/E Ratio

AXSMN/A

BLTEN/A

P/S Ratio

AXSM10.36x

BLTE0.00x

EV/Sales

AXSM10.21x

BLTE0.00x

EV/EBITDA

AXSM0.00x

BLTE0.00x

P/B Ratio

AXSM105.86x

BLTE7.97x

P/FCF Ratio

AXSMN/A

BLTEN/A

EV/FCF

AXSM-110.16x

BLTE0.00x

PEG Ratio

AXSMN/A

BLTEN/A

Forward P/E (NTM)

AXSM211.90x

BLTEN/A

Forward P/S (NTM)

AXSM6.58x

BLTE21.92x

Revenue (TTM)

AXSM$777M

BLTE$0

Revenue Growth (YoY)

AXSM56.9%

BLTEN/A

Forward Rev Growth

AXSM59.9%

BLTE97.1%

Gross Margin (TTM)

AXSM93.2%

BLTE0.0%

Operating Margin (TTM)

AXSM0.0%

BLTE0.0%

EBITDA Margin (TTM)

AXSM-23.0%

BLTE0.0%

Net Margin (TTM)

AXSM-24.7%

BLTE0.0%

FCF Margin (TTM)

AXSM-9.3%

BLTEN/A

Net Income (TTM)

AXSM$-192M

BLTE$-116M

FCF (TTM)

AXSM$-72M

BLTE$0

EPS (TTM)

AXSM-$3.70

BLTE-$3.07

ROE (TTM)

AXSM-25560.0%

BLTE-2687.0%

ROA (TTM)

AXSM-2705.0%

BLTE-2626.0%

ROIC (TTM)

AXSM-7042.0%

BLTE-2687.0%

Cash

AXSM$320M

BLTE$0

Debt

AXSM$202M

BLTE$0

Net Cash/Debt

AXSM$117M

BLTE$0

Current Ratio (TTM)

AXSM1.43x

BLTE50.02x

Quick Ratio (TTM)

AXSM1.30x

BLTE49.90x

Debt/Equity (TTM)

AXSM2.43x

BLTE0.00x

Debt/Assets (TTM)

AXSM0.0%

BLTE0.0%

Interest Coverage (TTM)

AXSMN/A

BLTEN/A

Net Debt/EBITDA (TTM)

AXSM0.00x

BLTE0.00x

Beta

AXSM0.79

BLTE-1.22

52W Performance

AXSM28.4%

BLTE91.6%

YTD Performance

AXSM-12.5%

BLTE-4.6%

% from 52W High

AXSM-39.9%

BLTE-24.1%

% from 52W Low

AXSM31.1%

BLTE92.9%

Asset Turnover (TTM)

AXSM1.10x

BLTE0.00x

FCF Yield (TTM)

AXSM-0.9%

BLTE0.0%

Earnings Yield (TTM)

AXSM-2.4%

BLTE-2.0%

Dividend Yield (TTM)

AXSMN/A

BLTEN/A

Rule of 40

AXSM47.6

BLTE0.0

EV/GP/RG

AXSM0.19

BLTEN/A

Ticker research

View AXSM research View BLTE research

Metric	AXSM Axsome Therapeutics Inc	BLTE Belite Bio Inc
Market & Valuation
Market Cap	$8.04B	$5.70B
Enterprise Value	$7.93B	$5.70B
Price	$156.32	$151.87
P/E Ratio	N/A	N/A
P/S Ratio	10.36x	0.00x
EV/Sales	10.21x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	105.86x	7.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-110.16x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	211.90x	N/A
Forward P/S (NTM)	6.58x	21.92x
Revenue & Growth
Revenue (TTM)	$777M	$0
Revenue Growth (YoY)	56.9%	N/A
Forward Rev Growth	59.9%	97.1%
Profitability
Gross Margin (TTM)	93.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-23.0%	0.0%
Net Margin (TTM)	-24.7%	0.0%
FCF Margin (TTM)	-9.3%	N/A
Net Income (TTM)	$-192M	$-116M
FCF (TTM)	$-72M	$0
EPS (TTM)	-$3.70	-$3.07
ROE (TTM)	-25560.0%	-2687.0%
ROA (TTM)	-2705.0%	-2626.0%
ROIC (TTM)	-7042.0%	-2687.0%
Financial Health
Cash	$320M	$0
Debt	$202M	$0
Net Cash/Debt	$117M	$0
Current Ratio (TTM)	1.43x	50.02x
Quick Ratio (TTM)	1.30x	49.90x
Debt/Equity (TTM)	2.43x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.79	-1.22
52W Performance	28.4%	91.6%
YTD Performance	-12.5%	-4.6%
% from 52W High	-39.9%	-24.1%
% from 52W Low	31.1%	92.9%
Efficiency & Yields
Asset Turnover (TTM)	1.10x	0.00x
FCF Yield (TTM)	-0.9%	0.0%
Earnings Yield (TTM)	-2.4%	-2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	47.6	0.0
EV/GP/RG	0.19	N/A
Ticker research	View AXSM research	View BLTE research

Valuation

P/S Ratio

BLTE

0.00x

AXSM

10.36x

EV/FCF

AXSM

-110.16x

BLTE

0.00x

Growth & revenue

Revenue Growth TTM

AXSM

56.9%

Forward Revenue Growth

BLTE

97.1%

AXSM

59.9%

Profitability & performance

Gross Margin

AXSM

93.2%

BLTE

0.0%

ROE

BLTE

-2687.0%

AXSM

-25560.0%

FCF Yield %

BLTE

0.0%

AXSM

-0.9%

52-Week Performance

BLTE

91.6%

AXSM

28.4%

Detailed metrics comparison

AXSM

Axsome Therapeutics Inc

BLTE

Belite Bio Inc

Market Cap

AXSM$8.04B

BLTE$5.70B

Enterprise Value

AXSM$7.93B

BLTE$5.70B

Price

AXSM$156.32

BLTE$151.87

P/E Ratio

AXSMN/A

BLTEN/A

P/S Ratio

AXSM10.36x

BLTE0.00x

EV/Sales

AXSM10.21x

BLTE0.00x

EV/EBITDA

AXSM0.00x

BLTE0.00x

P/B Ratio

AXSM105.86x

BLTE7.97x

P/FCF Ratio

AXSMN/A

BLTEN/A

EV/FCF

AXSM-110.16x

BLTE0.00x

PEG Ratio

AXSMN/A

BLTEN/A

Forward P/E (NTM)

AXSM211.90x

BLTEN/A

Forward P/S (NTM)

AXSM6.58x

BLTE21.92x

Revenue (TTM)

AXSM$777M

BLTE$0

Revenue Growth (YoY)

AXSM56.9%

BLTEN/A

Forward Rev Growth

AXSM59.9%

BLTE97.1%

Gross Margin (TTM)

AXSM93.2%

BLTE0.0%

Operating Margin (TTM)

AXSM0.0%

BLTE0.0%

EBITDA Margin (TTM)

AXSM-23.0%

BLTE0.0%

Net Margin (TTM)

AXSM-24.7%

BLTE0.0%

FCF Margin (TTM)

AXSM-9.3%

BLTEN/A

Net Income (TTM)

AXSM$-192M

BLTE$-116M

FCF (TTM)

AXSM$-72M

BLTE$0

EPS (TTM)

AXSM-$3.70

BLTE-$3.07

ROE (TTM)

AXSM-25560.0%

BLTE-2687.0%

ROA (TTM)

AXSM-2705.0%

BLTE-2626.0%

ROIC (TTM)

AXSM-7042.0%

BLTE-2687.0%

Cash

AXSM$320M

BLTE$0

Debt

AXSM$202M

BLTE$0

Net Cash/Debt

AXSM$117M

BLTE$0

Current Ratio (TTM)

AXSM1.43x

BLTE50.02x

Quick Ratio (TTM)

AXSM1.30x

BLTE49.90x

Debt/Equity (TTM)

AXSM2.43x

BLTE0.00x

Debt/Assets (TTM)

AXSM0.0%

BLTE0.0%

Interest Coverage (TTM)

AXSMN/A

BLTEN/A

Net Debt/EBITDA (TTM)

AXSM0.00x

BLTE0.00x

Beta

AXSM0.79

BLTE-1.22

52W Performance

AXSM28.4%

BLTE91.6%

YTD Performance

AXSM-12.5%

BLTE-4.6%

% from 52W High

AXSM-39.9%

BLTE-24.1%

% from 52W Low

AXSM31.1%

BLTE92.9%

Asset Turnover (TTM)

AXSM1.10x

BLTE0.00x

FCF Yield (TTM)

AXSM-0.9%

BLTE0.0%

Earnings Yield (TTM)

AXSM-2.4%

BLTE-2.0%

Dividend Yield (TTM)

AXSMN/A

BLTEN/A

Rule of 40

AXSM47.6

BLTE0.0

EV/GP/RG

AXSM0.19

BLTEN/A

Ticker research

View AXSM research View BLTE research

Metric	AXSM Axsome Therapeutics Inc	BLTE Belite Bio Inc
Market & Valuation
Market Cap	$8.04B	$5.70B
Enterprise Value	$7.93B	$5.70B
Price	$156.32	$151.87
P/E Ratio	N/A	N/A
P/S Ratio	10.36x	0.00x
EV/Sales	10.21x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	105.86x	7.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-110.16x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	211.90x	N/A
Forward P/S (NTM)	6.58x	21.92x
Revenue & Growth
Revenue (TTM)	$777M	$0
Revenue Growth (YoY)	56.9%	N/A
Forward Rev Growth	59.9%	97.1%
Profitability
Gross Margin (TTM)	93.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-23.0%	0.0%
Net Margin (TTM)	-24.7%	0.0%
FCF Margin (TTM)	-9.3%	N/A
Net Income (TTM)	$-192M	$-116M
FCF (TTM)	$-72M	$0
EPS (TTM)	-$3.70	-$3.07
ROE (TTM)	-25560.0%	-2687.0%
ROA (TTM)	-2705.0%	-2626.0%
ROIC (TTM)	-7042.0%	-2687.0%
Financial Health
Cash	$320M	$0
Debt	$202M	$0
Net Cash/Debt	$117M	$0
Current Ratio (TTM)	1.43x	50.02x
Quick Ratio (TTM)	1.30x	49.90x
Debt/Equity (TTM)	2.43x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.79	-1.22
52W Performance	28.4%	91.6%
YTD Performance	-12.5%	-4.6%
% from 52W High	-39.9%	-24.1%
% from 52W Low	31.1%	92.9%
Efficiency & Yields
Asset Turnover (TTM)	1.10x	0.00x
FCF Yield (TTM)	-0.9%	0.0%
Earnings Yield (TTM)	-2.4%	-2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	47.6	0.0
EV/GP/RG	0.19	N/A
Ticker research	View AXSM research	View BLTE research